The MAPK/ERK signaling pathway is one more critical target for inhibitors. Inhibitors targeting MAPK/ERK are used in cancer treatments to prevent unchecked cell spreading and lump growth.Antibiotics are a subset of inhibitors that have transformed the monitoring of bacterial infections. By targeting bacterial cell wall surfaces, protein synthesis,